IndraLab

Statements


| 7 1

reach
"An intricate study revealed that cisplatin and paclitaxel activate USP7, prompting CAFs to emit exosomal miR-522."

reach
"There is a study that suggested that cisplatin and paclitaxel promote miR-522 secretion from cancer-associated fibroblasts by activating the USP7/hnRNPA1 axis, leading to arachidonate lipoxygenase 15 suppression and decreased lipid-ROS accumulation in cancer cells, and ultimately resulting in decreased chemo-sensitivity [37]."
| PMC

reach
"Haiyang Zhang et al. found that cisplatin and paclitaxel promote miR-522 secretion from CAFs by activating the USP7/hnRNPA1 axis."

reach
"Paclitaxel and cisplatin promote miR-522 secretion from cancer-associated fibroblasts by activating USP7/hnRNPA1 axis, leading to arachidonate lipoxygenase 15 suppression and decreased lipid-ROS accumulation in cancer cells and ultimately promote acquired chemoresistance in gastric cancer (Zhang et al., 2020a)."

reach
"Importantly, cisplatin and paclitaxel promote miR-522 secretion from CAFs by activating USP7/hnRNPA1 axis, leading to ALOX15 suppression and decreased lipid-ROS accumulation in cancer cells, and ultimately result in decreased chemo-sensitivity."

reach
"Cisplatin also activates ubiquitin-specific protease 7 (USP7), which stabilizes heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) by deubiquitination [ 236 ]."

reach
"Cisplatin and paclitaxel activated the USP7/hnRNPA1 axis to upregulation of RNPA1 protein expression in GC cells."

sparser
"An intricate study revealed that cisplatin and paclitaxel activate USP7, prompting CAFs to emit exosomal miR-522 ."